Insmed (INSM) PT Raised to $40 at BofA Securities

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. TSLA
5. GNK

6. USO
7. AWK
8. ARGX
9. AZN
10. SPCX

February 23, 2024 6:30 AM EST

Price: $128.32 +3.70%

Rating Summary:
32 Buy, 1 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22

BofA Securities analyst Jason Zemansky raised the price target on Insmed (NASDAQ: INSM) to $40.00 (from $37.00) while maintaining a Buy rating.

Analyst PT Change

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!